ViaSat (Nasdaq: VSAT) reported its fiscal 2018 second quarters on Wednesday after the market close. Revenues of $393.1 million missed The Street’s expectation by roughly $9 million, but the company posted a surprising profit, earnings $0.09 per share, beating expectations for a $0.03 loss. After dipping at the open the… Read More
Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.
Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.
Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.
ChannelAdvisor (NYSE: ECOM) reported third-quarter results yesterday. After two good quarters to begin 2017, the third was unfortunately a disappointment. Plus, the company issued fourth-quarter guidance below analysts’ expectations. The end result is a steep decline in the stock price today. Revenues grew 8 percent year-on-year to $30.1 million. Variable… Read More
TAL Education (NYSE: TAL) reported fiscal 2018 second-quarter revenues of $456 million, a 68 percent year-over-year improvement, and earnings of $0.12 per ADR. Overall enrollment more than doubled. In local currency, renminbi (RMB) (removing the impact of the foreign-exchange rate by converting into dollar terms), the growth is actually an… Read More
Recent Brain Trust Profits addition Synchrony Financial (NYSE: SYF) gained roughly 4 percent on Friday after reporting strong third-quarter results. The company’s third-quarter net revenues (net interest income) increased 11 percent compared to a year ago to $3.88 billion. Net earnings of $555 million (or $0.70 per share) was 8.1… Read More
Core Growth Portfolio biotech holding Biogen Idec (Nasdaq: BIIB) has gained about 35 percent since the end of May as fears of a generic threat and revenue slowdown subsided. It set a new 52-week high last Friday after weekly sales of Tecfidera (the face of Biogen’s MS franchise) grew 3.1… Read More
Earlier today we welcomed Angiodynamics (Nasdaq: ANGO) to our portfolio, following the lead of BlackRock (NYSE: BLK), which has continued to accumulate shares in the company. The medical device maker has expanded from its humble beginnings in upstate New York into a global supplier with international presence in Europe and… Read More
Buy AngioDynamics (Nasdaq: ANGO). Today we add AngioDynamics to our portfolio, following the lead of BlackRock (NYSE: BLK), the largest global investment management corporation (by assets under management) in the world. Normally, when BlackRock owns a stock we aren’t overly impressed—after all, BlackRock literally holds thousands of stocks so an… Read More
Following the lead of two highly successful investing gurus dubbed “oracles” by Wall Street, we have just added Synchrony Financial (NYSE: SYF) to our portfolio. Both the Oracle of Omaha, Warren Buffett, and the Oracle of Boston, Seth Klarman, hold large stakes in the company. Buffett’s Berkshire Hathaway (NYSE: BRK.B)… Read More